MiMedx Group, Inc. (MDXG) Stock

MiMedx Group, Inc. (MDXG) is a Healthcare stock trading at $3.67 (as of 2026-06-18), with a market capitalization of $548.12M and a trailing P/E of 18.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

MiMedx Group, Inc. develops and distributes placental tissue allografts used in healthcare. Its product line includes EpiFix for chronic wound care, AmnioFix and related amnion/chorion or umbilical cord allografts for surgical recovery and wound healing, and AMNIOBURN for burn treatment.

Valuation — source: SEC EDGAR (first-party)
Price	$3.67
Market Cap	$548.12M
P/E Ratio	18.0
EV / EBITDA	7.3
Price / Book	2.21
Price / Sales	1.38
DCF Value (model)	$9.48
DCF Upside vs Price	158.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$418.63M
Net Margin	11.6%
Return on Equity	12.6%
Debt / Equity	0.07
Current Ratio	5.39
Revenue Growth (YoY)	-33.1%
EPS Growth (YoY)	-240.0%

Financial Health — source: SEC EDGAR
Altman Z-Score	6.21 (safe)
Piotroski F-Score	5/9 (moderate)

Valuation vs Sector & Industry
Stock P/E	18.0
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-13.9%
vs Industry	-43.1%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Essex Woodlands Management, Inc. ($111.37M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Joseph H. Capper
Employees	837
Country	US
IPO Date	2008-02-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.